Skip to main content
Livermore
Livermore
ZHEN

First Manhattan Co

SEC CIK
0000728083
Latest filing
Aug 14, 2026

OVID holding history

Ovid Therapeutics Inc. in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OVID overviewAll 13F holders of OVIDFull Q2 2026 holdings

Shares (Q2 2026)
26,000
Value
$69.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of OVID by First Manhattan Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,000$69.9K<0.1%00.0%UnchangedHolders
Q1 202626,000$57.7K<0.1%00.0%UnchangedHolders
Q4 202526,000$42.4K<0.1%00.0%UnchangedHolders
Q3 202526,000$33.8K<0.1%00.0%UnchangedHolders
Q2 202526,000$8.58K<0.1%00.0%UnchangedHolders
Q1 202526,000$8.11K<0.1%00.0%UnchangedHolders
Q4 202426,000$24.3K<0.1%00.0%UnchangedHolders
Q3 202426,000$30.7K<0.1%00.0%UnchangedHolders
Q2 202426,000$20.0K<0.1%00.0%UnchangedHolders
Q1 202426,000$79.3K<0.1%00.0%UnchangedHolders
Q4 202326,000$83.7K<0.1%00.0%UnchangedHolders
Q3 202326,000$99.8K<0.1%00.0%UnchangedHolders
Q2 202326,000$85.3K<0.1%00.0%UnchangedHolders
Q1 202326,000$67.1K<0.1%00.0%UnchangedHolders
Q4 202226,000$48.4K<0.1%00.0%UnchangedHolders
Q3 202226,000$47.0K<0.1%00.0%UnchangedHolders
Q2 202226,000$55.0K<0.1%00.0%UnchangedHolders
Q1 202226,000$81.0K<0.1%+18,000+225.0%AddedHolders
Q4 20218,000$25.0K<0.1%−18,000−69.2%ReducedHolders
Q3 202126,000$87.0K<0.1%00.0%UnchangedHolders
Q2 202126,000$101.0K<0.1%+8,000+44.4%AddedHolders
Q1 202118,000$72.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.